Polyoxometalate Catalyst Renders Nerve Agents Harmless
|
By HospiMedica International staff writers Posted on 30 Apr 2019 |

Image: Dr. Anatoly Frenkel next to the XPS powder diffraction beamline (Photo courtesy of BNL).
A new study describes a polyoxometalate (POM) catalyst that decomposes nerve agents, eliminating their harmful and lethal effects.
Researchers at Brookhaven National Laboratory (BNL; Upton, NY, USA) and Stony Brook University (SBU; NY, USA) conducted a study to investigate the decomposition process of the nerve agent Sarin and its simulant, dimethyl chlorophosphate (DMCP), using a zirconium polytungstate POM. To do so, they used x-ray photoelectron spectroscopy (XPS), a research technique that uses ultrabright x-rays to measure the elemental composition of a sample. They thus observed a change in the charge state of the zirconium atom in the POM molecule.
By comparing diffraction patterns, they found that the disordering of the zirconium-POM crystal lattice resulted in adsorption of the Sarin simulant molecules. Using computer models, they then showed that the resulting structural changes of the POM catalyst exposed zirconium atoms to Sarin, and that these interactions were responsible for the decomposition of DMCP by a tungstate monomerization process that activated nucleophilic hydrolysis. The study was published on April 19, 2019, in the Journal of Physical Chemistry Letters.
“Usually, a catalyst is a rigid structure that remains stable. Initially, this catalyst was a dimer, two big molecules connected by two bridging bonds. It looked like a bicycle with two wheels and a frame connecting them,” said lead author Anatoly Frenkel, PhD, of BNL and SBU. “What we understood after looking at the catalyst is that the bicycle broke into two 'wheels' and the 'frame' was cut. The process of breaking the dimer was equivalent to activating the catalyst.”
“Our work is part of an ongoing, multiagency effort to protect soldiers and civilians from chemical warfare agents,” concluded Dr. Frenkel. “The research requires us to understand molecular interactions on a very small scale, and to develop special characterization methods that are capable of observing those interactions. It is a very complex set of problems that also has a very immediate societal impact.”
Sarin is an extremely toxic synthetic organophosphorus compound generally considered as a weapon of mass destruction. A colorless, odorless liquid, it is an extremely potency nerve agent, with exposure lethal even at very low concentrations, and death occurring within ten minutes of direct inhalation of a lethal dose due to suffocation from lung muscle paralysis. People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage.
Related Links:
Brookhaven National Laboratory
Stony Brook University
Researchers at Brookhaven National Laboratory (BNL; Upton, NY, USA) and Stony Brook University (SBU; NY, USA) conducted a study to investigate the decomposition process of the nerve agent Sarin and its simulant, dimethyl chlorophosphate (DMCP), using a zirconium polytungstate POM. To do so, they used x-ray photoelectron spectroscopy (XPS), a research technique that uses ultrabright x-rays to measure the elemental composition of a sample. They thus observed a change in the charge state of the zirconium atom in the POM molecule.
By comparing diffraction patterns, they found that the disordering of the zirconium-POM crystal lattice resulted in adsorption of the Sarin simulant molecules. Using computer models, they then showed that the resulting structural changes of the POM catalyst exposed zirconium atoms to Sarin, and that these interactions were responsible for the decomposition of DMCP by a tungstate monomerization process that activated nucleophilic hydrolysis. The study was published on April 19, 2019, in the Journal of Physical Chemistry Letters.
“Usually, a catalyst is a rigid structure that remains stable. Initially, this catalyst was a dimer, two big molecules connected by two bridging bonds. It looked like a bicycle with two wheels and a frame connecting them,” said lead author Anatoly Frenkel, PhD, of BNL and SBU. “What we understood after looking at the catalyst is that the bicycle broke into two 'wheels' and the 'frame' was cut. The process of breaking the dimer was equivalent to activating the catalyst.”
“Our work is part of an ongoing, multiagency effort to protect soldiers and civilians from chemical warfare agents,” concluded Dr. Frenkel. “The research requires us to understand molecular interactions on a very small scale, and to develop special characterization methods that are capable of observing those interactions. It is a very complex set of problems that also has a very immediate societal impact.”
Sarin is an extremely toxic synthetic organophosphorus compound generally considered as a weapon of mass destruction. A colorless, odorless liquid, it is an extremely potency nerve agent, with exposure lethal even at very low concentrations, and death occurring within ten minutes of direct inhalation of a lethal dose due to suffocation from lung muscle paralysis. People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage.
Related Links:
Brookhaven National Laboratory
Stony Brook University
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







